Testosterone Treatment of Men With Mild Cognitive Impairment and Low Testosterone Levels

American Journal of Alzheimer's Disease and other Dementias

Volumn 30, Issue 4, 2015, Pages 421-430

  Cherrier, M M ^a   Anderson, K ^a   Shofer, J ^b   Millard, S ^b   Matsumoto, A M ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

cognition; low serum testosterone; mild cognitive impairment; quality of life; testosterone treatment; verbal memory

Indexed keywords

PLACEBO; TESTOSTERONE;

ADULT; AGED; ANDROGEN THERAPY; ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; VERBAL MEMORY; VERY ELDERLY; BLOOD; DRUG EFFECTS; MEMORY; MIDDLE AGED; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DEPRESSION; DOUBLE-BLIND METHOD; HUMANS; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; QUALITY OF LIFE; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84930511866     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317514556874     Document Type: Article

References (49)

1. Hogervorst E, Bandelow S, Combrinck M, Smith AD. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004 ; 39 (11-12). 1633-1639
2. Moffat SD, Zonderman AB, Metter EJ, Smith AD. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004 ; 62 (2). 188-193
3. Chu LW, Tam S, Lee PW, et al. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol (Oxf). 2008 ; 68 (4). 589-598
4. Chu LW, Tam S, Wong RL, et al. Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men. J Alzheimers Dis. 2010 ; 21 (4). 1335-1345
5. Morley JE, Kaiser F, Raum WJ, et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progessive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor to 1 growth hormone. Proc Natl Acad Sci U S A. 1997 ; 94 (14). 7537-7542
6. Cherrier MM, Asthana S, Baker LD, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001 ; 57 (1). 80-88
7. Gray PB, Singh AB, Woodhouse LJ, et al. Dose-dependent effects of testosterone on sexual function, mood and visuospatial cognition in older men. J Clin Endocrinol Metab. 2005 ; 90 (7). 3838-3846
8. Maki PM, Ernst M, London ED, et al. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab. 2007 ; 92 (11). 4107-4114
9. Kenny AM, Fabregas G, Song C, Biskup B, Bellantonio S. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci. 2004 ; 59 (1). 75-78
10. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004 ; 256 (3). 183-194
11. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 ; 43 (8). 1467-1472
12. Harrison J, Minassian SL, Jenkins L, Black RS, Koller M, Grundman M. A neuropsychological test battery for use in Alzheimer disease clinical trials. Arch Neurol. 2007 ; 64 (9). 1323-1329
13. Beglinger LJ, Gaydos B, Tangphao-Daniels O, et al. Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol. 2005 ; 20 (4). 517-529
14. Sullivan K. Alternate forms of prose passages for the assessment of auditory-verbal memory. Arch Clin Neuropsychol. 2005 ; 20 (6). 745-753
15. Mitrushina M, Satz P, Chervinsky A, D'Elia L. Performance of four age groups of normal elderly on the Rey Auditory-Verbal Learning Test. J Clin Psychol. 1991 ; 47 (3). 351-357
16. Tiernan KN, Schenk K, Swadberg D, et al. Puget sound route learning test: examination of the validity and reliability of a novel route test in healthy older adults and Alzheimer's disease patients. Clin Psychol. 2004 ; 8 (1). 39-42
17. Malec JF, Ivnik RJ, Smith GE, et al. Visual spatial learning test: normative data and further validation. Psychol Assess. 1992 ; 4 (4). 433-441
18. Groth-Marnat G, Teal M. Block design as a measure of everyday spatial ability: a study of ecological validity. Percept Mot Skills. 2000 ; 90 (2). 522-526
19. Wechsler D WAIS-III Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation ; 1997:
20. Spreen O, Strauss E A compendium of neuropsychological tests. New York, NY: Oxford University Press ; 1991:
21. McNair DM, Lorr M, Droppleman LF Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service ; 1992:
22. Galasko D, Bennett A, Sano M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzeheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997 ; 11 (suppl 2). S33 - S39
23. Troyer AK, Rich JB. Psychometric properties of a new metamemory questionnaire for older adults. J Gerontol B Psychol Sci Soc Sci. 2002 ; 57 (1). P19 - P27
24. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988 ; 24 (4). 709-711
25. Ware JE, Snow KK, Kosinski M, et al SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute ; 1993:
26. Page ST, Hirano L, Gilchriest J, et al. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy. J Urol. 2011 ; 186 (1). 191-197
27. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999 ; 84 (10). 3666-3672
28. Fukai S, Akishita M, Yamada S, Toba K, Ouchi Y. Effects of testosterone in older men with mild-to-moderate cognitive impairment. J Am Geriatr Soc. 2010 ; 58 (7). 1419-1421
29. Vaughan C, Goldstein FC, Tenover JL. Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone. J Androl. 2007 ; 28 (6). 875-8821
30. Kenny AM, Bellantonio S, Gruman CA, Acosta RD, Prestwood KM. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci. 2002 ; 57 (5). M321 - M325
31. Cherrier MM, Matsumoto AM, Amory JK, et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 2005 ; 64 (12). 2063-2068
32. Cherrier MM, Asthana S, Plymate S, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001 ; 57 (1). 80-88
33. Hawley WR, Grissom EM, Martin RC, Halmos MB, Bart CL, Dohanich GP. Testosterone modulates spatial recognition memory in male rats. Horm Behav. 2013 ; 63 (4). 559-565
34. Tan RS, Pu SJ. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male. 2003 ; 6 (1). 13-17
35. Lu PH, Masterman DA, Mulnard R, et al. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol. 2006 ; 63 (2). 177-185
36. Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci. 2006 ; 26 (51). 13384-13389
37. Gandy S, Almeida OP, Fonte J, et al. Chemical andropause and amyloid-beta peptide. JAMA. 2001 ; 285 (17). 2195-2196
38. Ramsden M, Nyborg AC, Murphy MP, et al. Androgens modulate B-amyloid levels in male rat brain. J Neurochem. 2003 ; 87 (4). 1052-1055
39. Pike CJ, Rosario ER, Nguyen TV. Androgens, Aging, and Alzheimer's Disease. Endocrine. 2006 ; 29 (2). 233-241
40. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002 ; 87 (11). 5001-5007
41. Chodosh J, Kado DM, Seeman TE, Karlamangla AS. Depressive symptoms as a predictor of cognitive decline: MacArthur Studies of Successful Aging. Am J Geriatr Psychiatry. 2007 ; 15 (5). 406-415
42. Richard E, Schmand B, Eikelenboom P, et al. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Dement Geriatr Cogn Disord. 2012 ; 33 (2-3). 204-209
43. Shores MM, Moceri VM, Gruenewald DA, Brodkin KI, Matsumoto AM, Kivlahan DR. Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. J Am Geriatr Soc. 2004 ; 52 (12). 2077-2081
44. Seidman SN, Weiser M. Testosterone and mood in aging men. Psychiatr Clin North Am. 2013 ; 36 (1). 177-182
45. Basaria S, Davda MN, Travison TG, Ulloor J, Singh R, Bhasin S. Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci. 2013 ; 68 (2). 153-160
46. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010 ; 95 (6). 2536-2559
47. Anawalt BD, Hotaling JM, Walsh TJ, Matsumoto AM. Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism. J Urol. 2012 ; 187 (4). 1369-1373
48. Brambilla DJ, O'Donnell AB, Matsumoto AM, McKinlay JB. Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol (Oxf). 2007 ; 67 (6). 853-862
49. Schoenfeld MJ, Shortridge E, Cui Z, Muram D. Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: a retrospective medical claims analysis. J Sex Med. 2013 ; 10 (5). 1401-1409